NASDAQ:PRVB
Delisted

Provention Bio Stock Predictions

etoro logo Buy PRVB
*Your capital is at risk
$24.98
+0 (+0%)
At Close: Jul 24, 2023
Currently predicting for Mon, 8 Jun 2026

PRVB Prediction Chart

PRVB Predictions History

Latest community submissions for PRVB.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Nov 5, 2020 $14.34 +7.34% $13.36 X 92.66% 0
JS JS Pro
Oct 26, 2020 $13.08 +3.81% $12.60 X 96.19% 1
iHustle84 iHustle84 Pro
Oct 26, 2020 $14.78 +17.30% $12.60 X 82.70% 0
JS JS Pro
Oct 19, 2020 $13.91 +4.12% $13.36 X 95.88% 0
JS JS Pro
Oct 9, 2020 $15.13 +0.67% $15.03 X 99.33% 4
iHustle84 iHustle84 Pro
Oct 9, 2020 $15.89 +5.72% $15.03 X 94.28% 1
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 8, 2020 $11.15 -4.13% $11.63 X 95.87% 0
iHustle84 iHustle84 Pro
Sep 8, 2020 $10.00 -14.02% $11.63 X 85.98% 0
JS JS Pro
Sep 8, 2020 $10.81 -7.05% $11.63 X 92.95% 0
JS JS Pro
Jan 21, 2020 $17.22 -2.99% $17.75 X 97.01% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PRVB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT PROVENTION BIO INC.
Provention Bio
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE